Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

Yoshihito Kogure; Masahide Oki; Hideo Saka

doi:10.1016/j.jtho.2018.11.029

Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

Yoshihito Kogure, Masahide Oki, Hideo Saka

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e74-e75
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	4
DOIs	https://doi.org/10.1016/j.jtho.2018.11.029
Publication status	Published - 04-2019
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.jtho.2018.11.029

Cite this

@article{53932a61d1064c20a3cb931041c15298,

title = "Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab",

author = "Yoshihito Kogure and Masahide Oki and Hideo Saka",

year = "2019",

month = apr,

doi = "10.1016/j.jtho.2018.11.029",

language = "English",

volume = "14",

pages = "e74--e75",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

AU - Kogure, Yoshihito

AU - Oki, Masahide

AU - Saka, Hideo

PY - 2019/4

Y1 - 2019/4

UR - https://www.scopus.com/pages/publications/85063197672

UR - https://www.scopus.com/inward/citedby.url?scp=85063197672&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2018.11.029

DO - 10.1016/j.jtho.2018.11.029

M3 - Letter

C2 - 30922582

AN - SCOPUS:85063197672

SN - 1556-0864

VL - 14

SP - e74-e75

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this